Some people struggle to find their paths in life. Not Chris Mason, PhD, Associate Professor and geneticist at Weill Cornell Medicine in New York City. He had already determined he wanted to be a geneticist by the time he reached eighth grade. “I was—and still am—a curious kid. I wanted to know how the world … Continued
Ali Brivanlou slides open a glass door at the Rockefeller University in New York to show off his latest experiments probing the mysteries of the human embryo. “As you can see, all my lab is glass — just to make sure there is nothing that happens in some dark rooms that gives people some weird … Continued
The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue explorative and high-risk/high-reward research at a stage when traditional funding is lacking.
The Pershing Square Sohn Cancer Research Alliance (“the Alliance”) today announced seven winners of the third annual Pershing Square Sohn Prize for Young Investigators in Cancer Research (“the Pershing Square Sohn Prize”). Each will receive $200,000 in funding per year for up to three years to enable them to continue to pursue explorative and high-risk/high-reward research.
President Obama calls the quest to cure cancer the “moon shot” of his presidency. But if the federal government has its way, this rocket may never leave the launchpad.
Geneticist Jennifer Doudna on the controversy about Crispr-Cas9, a technique that could potentially cure genetic diseases.
A Proposal from FasterCures by Melissa Stevens (Milken Institute Review) - In the past few years, the media has showered us with headlines about recordsetting biotech financing – outsized venture-capital rounds, unprecedented public market appetite for IPOs, and robust sector returns. But a closer look suggests there is more froth than substance at this frontier of medicine and science.
For the National Institutes of Health and its supporters, 2015 could turn out to be a pretty good year. As Congress continues negotiations on a mammoth omnibus spending package, advocates are hopeful that their favored institution is becoming a congressional priority again—and that an extended period of uncertainty may be coming to a close.
Abstract: Before completing a PhD in immunology at the Humbolt University of Berlin, Christine Mayr received a medical degree from the Freie Universität Berlin. She received postdoctoral training with Michael Hallek at the Ludwig Maximillian University in Munich.
WASHINGTON — One day last winter, desperate as his son fought for his life against a killer brain cancer, Vice President Joseph R. Biden Jr. and his family reached out to one of America’s most famous, and controversial, doctors for help.